about
Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.Cerebrospinal fluid leakage in Gorham-Stout disease due to dura mater involvement after progression of an osteolytic lesion in the thoracic spine.When the Infection Hits the Wound: Matched Case-Control Study in a Neurosurgical Patient Collective Including Systematic Literature Review and Risk Factors Analysis.Glioma tissue obtained by modern ultrasonic aspiration with a simple sterile suction trap for primary cell culture and pathological evaluation.Aquaporin-4 in glioma and metastatic tissues harboring 5-aminolevulinic acid-induced porphyrin fluorescence.Quality Indicators in Cranial Neurosurgery: Which Are Presently Substantiated? A Systematic Review.Simultaneous fluorescein sodium and 5-ALA in fluorescence-guided glioma surgeryWhere and When to Cut? Fluorescein Guidance for Brain Stem and Spinal Cord Tumor Surgery-Technical Note.Initial psycho-oncological counselling in neuro-oncology: analysis of topics and needs of brain tumour patients.The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients.Fluorescence Imaging/Agents in Tumor Resection.Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature.The difficulty of predicting clinical outcome after intended submaximal resection of large vestibular Schwannomas.Zephalozele der Felsenbeinspitze: seltene Ursache einer Trigeminusneuralgie.[Cephalocele of the petrous apex: a rare etiology of trigeminal neuralgia].Access to Meckel's cave for biopsies of indeterminate lesions: a systematic reviewThe rise of quality indicators in neurosurgery: 30-day unplanned reoperation rate evaluated in 3760 patients-a single-center experienceIntracavitary radioimmunotherapy of high-grade gliomas: present status and future developments
P50
Q36321753-3B0718C7-5F8A-4098-B303-88E4071C2D2AQ38261049-6F879FDB-31CA-47D8-9F09-0244939BC1A4Q38923049-FDF922FA-48D3-4E7B-8B25-18521CCB3F42Q38971990-072C080D-823A-47E5-A3D4-1076F13ECF4BQ39115312-AAA5A645-2AB6-4E9C-AF6A-1CA8A3F152FCQ39279175-0980FD55-009C-4475-A60C-935F802E9BAEQ42410552-B44E0CA4-B8E6-4642-8B3F-3968965E81FAQ47215430-785B4601-E061-434A-ADDC-75852ABC72DCQ47610527-A5826BBB-7420-4938-B5B6-E4E4B43EA5E7Q47758126-65657B80-081B-4D0E-887E-1F5894428697Q47868028-B36EC3D0-AB58-44BE-9179-D6BDA3CD9FC4Q47945754-F88949DF-F45F-4944-ACFE-EC5B3BAD0ED8Q48333568-73FF92D7-0CB1-47FA-84D3-6D74BDEFF0B2Q50048501-52B15E42-95C5-415E-9466-D810B18C8B08Q50206015-1F3ED54C-704C-48B1-96BC-B126838AD8ECQ53452972-9459B6A5-44B1-43AC-AD76-66ACF73D69D6Q89630648-CE9C02AC-1257-4FB3-9443-5796AF898596Q91700239-C82676B5-50CD-4AEB-9CE5-01D61CB5C1F3Q93067219-C5245BD0-7DB5-4698-A593-E50BCD18245A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
E J Suero Molina
@en
E J Suero Molina
@nl
type
label
E J Suero Molina
@en
E J Suero Molina
@nl
prefLabel
E J Suero Molina
@en
E J Suero Molina
@nl
P31
P496
0000-0001-5652-2105